Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET).
Jerusalem G, Mariani G, Ciruelos EM, Martin M, Tjan-Heijnen VC, Neven P, Gavila JG, Michelotti A, Montemurro F, Generali D, Simoncini E, Lang I, Mardiak J, Naume B, Camozzi M, Lorizzo K, Bianchetti S, Conte P. Jerusalem G, et al. Among authors: lorizzo k. Ann Oncol. 2016 Sep;27(9):1719-25. doi: 10.1093/annonc/mdw249. Epub 2016 Jun 29. Ann Oncol. 2016. PMID: 27358383 Free article. Clinical Trial.
Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
Sanna G, Lorizzo K, Rotmensz N, Bagnardi V, Cinieri S, Colleoni M, Nolè F, Goldhirsch A. Sanna G, et al. Among authors: lorizzo k. Ann Oncol. 2007 Feb;18(2):288-92. doi: 10.1093/annonc/mdl399. Epub 2006 Nov 6. Ann Oncol. 2007. PMID: 17088328 Free article.
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.
Lorizzo K, Fazio N, Radice D, Boselli S, Ariu L, Zampino MG, Nolè F, Magni E, Ardito R, Minchella I, Rocca A, Di Meglio G, Squadroni M, de Braud F. Lorizzo K, et al. Cancer Chemother Pharmacol. 2009 Jul;64(2):301-6. doi: 10.1007/s00280-008-0871-y. Epub 2008 Nov 26. Cancer Chemother Pharmacol. 2009. PMID: 19034450
Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study.
Curigliano G, Spitaleri G, Magni E, Lorizzo K, De Cobelli O, Locatelli M, Fumagalli L, Adamoli L, Cossu Rocca M, Verri E, De Pas T, Jereczek-Fossa B, Martinelli G, Goldhirsch A, Nolè F. Curigliano G, et al. Among authors: lorizzo k. J Chemother. 2009 Dec;21(6):687-92. doi: 10.1179/joc.2009.21.6.687. J Chemother. 2009. PMID: 20071294
Pre-operative radiochemotherapy with raltitrexed for resectable locally-advanced rectal cancer: a phase II study.
Leonardi MC, Zampino MG, Luca F, Jereczek-Fossa BA, Petazzi E, Tatani B, Lazzari R, Biffi R, Lorizzo K, Magni E, Scanniffio D, Orsi F, Bonomo G, Petralia G, Trovato C, Crosta C, Andreoni B, Orecchia R. Leonardi MC, et al. Among authors: lorizzo k. Anticancer Res. 2006 May-Jun;26(3B):2419-23. Anticancer Res. 2006. PMID: 16821626 Free article. Clinical Trial.
Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Fazio N, Biffi R, Curigliano G, Lorizzo K, Zampino MG, de Braud F, Chiappa A, Roth A, Goldhirsch A. Fazio N, et al. Among authors: lorizzo k. J Natl Cancer Inst. 2007 Sep 5;99(17):1345-6; author reply 1346-7. doi: 10.1093/jnci/djm092. Epub 2007 Aug 28. J Natl Cancer Inst. 2007. PMID: 17728219 Free article. No abstract available.
20 results